- June 10, 2025Seasoned medtech executive joins as hospital adoption accelerates for breakthrough diagnostic in acute infection and sepsis care Sunnyvale, Calif., June…
- September 12, 2024Fundraise brings lead product, TriVerity™ Test, closer to commercialization following recent submission to FDA. Sunnyvale, Calif., September 12, 2024 — Inflammatix,…
- November 28, 2023Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage. Sunnyvale, Calif., November 28, 2023 — Inflammatix, Inc., a…
- November 15, 2023Company Reaches Important Product Development Milestone with its Myrna™ Instrument and TriVerity Cartridge. Sunnyvale, Calif., November 15, 2023 — Inflammatix, Inc.,…
- September 13, 2023Data-biobank Acutelines and Inflammatix, an innovative molecular diagnostics company, are joining forces to improve the early detection of sepsis: a…